TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model

por Meraz, Ismail M., Majidi, Mourad, Shao, RuPing, Meng, Feng, Ha, Min Jin, Shpall, Elizabeth, Roth, Jack A.
Publicado 2022

RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer

por Guo, Chengcheng, Hao, Chuncheng, Shao, RuPing, Fang, Bingliang, Correa, Arlene M., Hofstetter, Wayne L., Roth, Jack A., Behrens, Carmen, Kalhor, Neda, Wistuba, Ignacio I., Swisher, Stephen G., Pataer, Apar
Publicado 2015

Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells

por Pataer, Apar, Ozpolat, Bulent, Shao, RuPing, Cashman, Neil R., Plotkin, Steven S., Samuel, Charles E., Lin, Steven H., Kabil, Nashwa N., Wang, Jing, Majidi, Mourad, Fang, Bingliang, Roth, Jack A., Vaporciyan, Ara A., Wistuba, Ignacio I., Hung, Mien-Chie, Swisher, Stephen G.
Publicado 2019

3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

por Meraz, Ismail M., Majidi, Mourad, Fang, Bingliang, Meng, Feng, Gao, Lihui, Shao, RuPing, Song, Renduo, Li, Feng, Lissanu, Yonathan, Chen, Huiqin, Ha, Min Jin, Wang, Qi, Wang, Jing, Shpall, Elizabeth, Jung, Sung Yun, Haderk, Franziska, Gui, Philippe, Riess, Jonathan Wesley, Olivas, Victor, Bivona, Trever G., Roth, Jack A.
Publicado 2023

Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

por Meraz, Ismail M., Majidi, Mourad, Fang, Bingliang, Meng, Feng, Gao, Lihui, Shao, RuPing, Song, Renduo, Li, Feng, Lissanu, Yonathan, Chen, Huiqin, Ha, Min Jin, Wang, Qi, Wang, Jing, Shpall, Elizabeth, Jung, Sung Yun, Haderk, Franziska, Gui, Philippe, Riess, Jonathan Wesley, Olivas, Victor, Bivona, Trever G., Roth, Jack A.
Publicado 2023